NCT05284656View on ClinicalTrials.gov

Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 8, 2022

Primary Completion Date

June 12, 2026

Study Completion Date

December 19, 2026

Conditions
Chronic Kidney Diseases
Interventions
DRUG

combination of Pentoxifylline 400 MG and Folic Acid

drugs used to delay progression of chronic kidney disease

DRUG

folic acid

drugs used to delay progression of chronic kidney disease

DRUG

Pentoxifylline 400 MG

drugs used to delay progression of chronic kidney disease

Trial Locations (1)

Unknown

Al Azhar University, Cairo

All Listed Sponsors
lead

Al-Azhar University

OTHER